MaxCyte Inc (MXCT)

IN BRIEF: MaxCyte CEO Maher Masoud buys 100,000 shares | Financial News - London South East

London South East

MaxCyte, Inc. (NASDAQ:MXCT) CEO Maher Masoud Buys 70443 Shares - Defense World

Defense World

Insider Buying: President and CEO Maher Masoud Acquires 100,000 Shares of MaxCyte Inc (MXCT) - Yahoo Finance

Yahoo Finance

Insider Buying: President and CEO Maher Masoud Acquires 100,000 Shares of MaxCyte Inc (MXCT) - Yahoo Finance Australia

Yahoo Finance Australia

Insider Buying: President and CEO Maher Masoud Acquires 100,000 Shares of MaxCyte Inc (MXCT) By GuruFocus - Investing.com Canada

Investing.com Canada

Maxcyte CEO Maher buys $489k in company stock By Investing.com - Investing.com Australia

Investing.com Australia

Maxcyte CEO Maher buys $489k in company stock By Investing.com - Investing.com

Investing.com

Cadian Capital Management LP Invests $26.53 Million in MaxCyte, Inc. (NASDAQ:MXCT) - MarketBeat

MarketBeat

MaxCyte, Inc. (NASDAQ:MXCT) CEO Maher Masoud Purchases 29,557 Shares - MarketBeat

MarketBeat

MaxCyte (LON:MXCT) Share Price Passes Above 50 Day Moving Average of $338.25 - MarketBeat

MarketBeat

MaxCyte (LON:MXCT) Stock Crosses Above 50 Day Moving Average of $338.25 - Defense World

Defense World

MaxCyte Inc (MXCT) Stock: From Low to High in 52 Weeks - The InvestChronicle

The InvestChronicle

A better buy-in window may exist right now for MaxCyte Inc (MXCT) – Sete News - SETE News

SETE News

MaxCyte, Inc. (NASDAQ:MXCT) Stock Holdings Lifted by Mudita Advisors LLP - MarketBeat

MarketBeat

MaxCyte (NASDAQ:MXCT) Shares Gap Up to $4.59 - MarketBeat

MarketBeat

After a strong run, what's next for investors in Maxcyte Inc? - Yahoo Lifestyle UK

Yahoo Lifestyle UK

MaxCyte Issues Equity Update and Block Listing Return - TipRanks.com - TipRanks

TipRanks

Swiss National Bank Sells 16900 Shares of MaxCyte, Inc. (NASDAQ:MXCT) - Defense World

Defense World

MaxCyte Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance - br.ADVFN.com

br.ADVFN.com

Investors Appear Satisfied With MaxCyte, Inc.'s (LON:MXCT) Prospects As Shares Rocket 27% - Simply Wall St

Simply Wall St

Victory Capital Management Inc. Boosts Stake in MaxCyte, Inc. (NASDAQ:MXCT) - Defense World

Defense World

MaxCyte to Showcase at Top Growth Stock Conference - TipRanks

TipRanks

Participation in Upcoming Investor Conference - ShareCast

ShareCast

MaxCyte to Participate in William Blair 44th Annual Growth Stock Conference - ForexTV.com

ForexTV.com

MaxCyte to Participate in William Blair 44th Annual Growth Stock Conference

GlobeNewswire Inc.

What We Learned About MaxCyte's (LON:MXCT) CEO Compensation - Yahoo Movies UK

Yahoo Movies UK

What We Learned About MaxCyte's (LON:MXCT) CEO Compensation - Yahoo Movies UK

Yahoo Movies UK

The Significance of Moving Averages in MaxCyte Inc Inc. (MXCT) Price Performance - The InvestChronicle

The InvestChronicle

After a strong run, what's next for investors in Maxcyte Inc? - Yahoo Lifestyle UK

Yahoo Lifestyle UK

With 64% ownership of the shares, MaxCyte, Inc. (LON:MXCT) is heavily dominated by institutional owners - Yahoo Finance

Yahoo Finance

BlackRock Acquires Major Stake in MaxCyte - TipRanks.com - TipRanks

TipRanks

Legend Biotech Obtains Electroporation Technology License from MaxCyte Covering Cell-Based Therapies - Genetic Engineering & Biotechnology News

Genetic Engineering & Biotechnology News

MaxCyte Partners with Legend Biotech for Cell Therapy Advancements - TipRanks.com - TipRanks

TipRanks

MaxCyte Signs Strategic Platform License Agreement with Legend Biotech to Accelerate Cell Therapy Discovery and Development - ForexTV.com

ForexTV.com

Signing of Strategic Platform License - ShareCast

ShareCast

Signing of Strategic Platform License - ShareCast

ShareCast

Signing of Strategic Platform License - ShareCast

ShareCast

BlackRock Increases Stake in MaxCyte, Inc. - TipRanks

TipRanks

Massachusetts Financial Services Co. MA Grows Stock Holdings in MaxCyte, Inc. (NASDAQ:MXCT) - MarketBeat

MarketBeat

MaxCyte Inc [MXCT] Director makes an insider sale of 5000 shares worth $22025.0. – Knox Daily - Knox Daily

Knox Daily

COVID-19 Impact Analysis of Transfection Technologies Market 2031 | Key Players Bio-Rad, Polyplus Transfection ... - Amoré

Amoré

FY2024 EPS Estimates for MaxCyte, Inc. Boosted by Analyst (NASDAQ:MXCT) - MarketBeat

MarketBeat

FY2024 EPS Estimates for MaxCyte, Inc. Boosted by Analyst (NASDAQ:MXCT) - MarketBeat

MarketBeat

Roubaix Capital LLC Invests $1.82 Million in MaxCyte, Inc. (NASDAQ:MXCT) - MarketBeat

MarketBeat

MaxCyte, Inc. (NASDAQ:MXCT) Q1 2024 Earnings Call Transcript - Insider Monkey

Insider Monkey

MaxCyte, Inc. (NASDAQ:MXCT) Q1 2024 Earnings Call Transcript - Insider Monkey

Insider Monkey

Roubaix Capital LLC Invests $1.82 Million in MaxCyte, Inc. (NASDAQ:MXCT) - MarketBeat

MarketBeat

Earnings call: MaxCyte sees steady growth and strategic partnerships in Q1 2024 By Investing.com - Investing.com Canada

Investing.com Canada

Earnings call: MaxCyte sees steady growth and strategic partnerships in Q1 2024 - Investing.com

Investing.com

Earnings call: MaxCyte sees steady growth and strategic partnerships in Q1 2024 By Investing.com - Investing.com Canada

Investing.com Canada